Lenovo Shares Surge Nearly 20 on Record Earnings and AI Revenue Growth US Equity Funds See Outflows as Investors Eye Higher Bond Yields Gold Holds Above 4500 Support as USIran Tensions Intensify Robinhood Launches AI Agent Trading Users Can Deploy Autonomous Bots for Stock Trading and Credit Card Purchases April CPI Inflation Accelerates to 38 Annually Topping Expectations and Marking Highest Since May 2023 Micron Stock Rises as UBS Lifts Price Target on AI Growth Prospects MYR Group Q1 2026 Earnings EPS Surges 44 Above Estimates Shares Climb Nearly 4 MG Q1 2026 Earnings EPS Beats Estimates by 553 as Company Reports Profitability Summit Hotel Properties Inc INN Q1 2026 Earnings Narrower Loss Beats Estimates Amid Hotel Sector Recovery Vaxcyte PCVX Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Gains on Pipeline Confidence H2O America HTO Q1 2026 Earnings EPS Beats Estimates as Stock Edges Higher BSET Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Cantaloupe Inc CTLP Holds Steady at 1120 as Traders Eye Key Support and Resistance Levels Agencia Comercial Spirits Ltd AGCC Climbs 268 as Bulls Test Key Resistance Level Tectonic Therapeutic Inc TECX Slips 253 as Biotech Sentiment Weighs on Shares Herbalife HLF Surges 2 Breaking Out of Consolidation or Temporary Relief Core Scientific Warrants CORZW Gain 216 as Resistance Test Approaches Spb Stock Analysis Spectrum Brands Holdings Inc. Rises 0.80 To 74.29 On Solid Staples Sector Momentum 20260401 Pasg Stock Analysis Passage Bio Inc. Biotech Posts 2.93 Pct Gain To 8.08 Review 20260403 1 What Is Market Pressure On Jiayin Jfin Stock Price At 4.19 Up 5.81 20260402 What Is The Dividend Outlook For Mount Mlcil Stock Price At 23.10 Down 0.60 20260402 Is Washington Wash Stock Moving Higher Wash Q4 Earnings Beats Estimates By 0.07 20260410 1 Nus Stock Analysis Nu Skin Enterprises Inc. At 7.41 0.68 Percent Daily Gain Key Outlook 20260403 1 Meta to Test AI Subscription Services Starting at 799 per Month DFTX Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Decoy Therapeutics Surges 55 Breakout Potential for DCOY Stock